TERT and glioblastoma: cIMPACT-NOW Update 3 recommended TERT promoter mutations as one of the three criteria (the other two being either EGFR amplification or combined whole chromosome 7 gain/chromosome 10 loss) to diagnosis “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” [8].